Rising incidence of orthopedic disorders is expected to drive the growth of Europe bio-implants market
According to TechSci Research report, “Europe Bio-Implants Market By Type (Cardiovascular Bioimplants, Dental Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants, and Ophthalmology Bioimplants), By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, Alloys and Natural Biomaterials), By Origin (Autograft, Allograft, Synthetic, and Others), By End-User (Hospitals, Clinics, Specialty Centers and Others), By Country, Competition, Forecast & Opportunities, 2025”, Europe bio-implants market is expected to witness significant CAGR during the forecast period. Growing R&D activities is one of the major factors accounting for the growth of Europe bio-implants market. For instance, several pacemaker manufacturers are focusing more towards developing MRI-conditional and leadless pacemakers, which is expected to boost the market growth. Moreover, increase in incidences of chronic diseases such as osteoarthritis, old age-related trauma, neuropathic disorders, congenital disorders, among others, is expected to bode well for the growth of Europe bio-implants market through the forecast period. In addition to this, there are certain advantage of bio-implants through the conventional forms of implants such as it is a fast method of treatment with negligible complications, which is projected to positively influence the growth of Europe bio-implants market in the years to come. Also, rising adoption of cosmetic surgeries, is further making headway for the growth of Europe bio-implants market over the coming years. However, there are some factors that might act as major impediments to the growth of Europe bio-implants market through 2025 including high treatment costs and reimbursement issues.
Browse XX market data Tables and XX Figures spread through XXX Pages and an in-depth TOC on “ Europe Bio-Implants Market “
Europe bio-implants market can be segmented based on type, material, origin, end-user, company, and region. In terms of origin, the market can be categorized into autograft, allograft, synthetic, and others. Among these, the allografts segment is expected to register high growth in the next five years which is attributable to benefits such as lower risk of harvest site morbidity, reduced postoperative pain, as well as shorter surgical and recovery time. Based on type, the market can be categorized into cardiovascular bioimplants, dental bioimplants, orthopedic bioimplants, spinal bioimplants, and ophthalmology bioimplants. Out of these, the cardiovascular bioimplants segment dominated the market in terms of largest market share until 2019 and is expected to maintain its dominance during the forecast period as well which is mainly attributed to rising prevalence of cardiovascular diseases. Along with this, dental implants are expected to grow at a high pace during the forecast period due to growing ageing population with more tooth deformities. Moreover, increasing demand for dental and cosmetic surgeries is further anticipated to contribute to the segmental growth over the coming years.
Medtronic Plc., St. Jude Medical Inc., Stryker Corporation, Boston Scientific Corporation, Gore (WL) & Associates Incorporated, Abbott Laboratories, Braun (B.) Melsungen AG, Zimmer Biomet Holdings Inc., Orthofix Holdings, Inc., Wright Medical Group N.V., Johnson & Johnson Services, Inc., Integra Life Sciences, Smith & Nephew Plc, Exactech, Inc., Cochlear Ltd are among others are the leading players operating in Europe bio-implants market. The players are adopting several growth strategies to enhance the market scenario of bio-implants. Other competitive strategies include new technological developments; new product launches, extensive research activities, mergers & acquisitions; agreements, partnerships, and collaborations; and expansions to diverse their product portfolio in order to strengthen their market position.
download sample report @ https://www.techsciresearch.com/sample-report.aspx?cid=4963
customers can also request for 10% free customization on this report.
“Europe bio-implants market is anticipated to register high growth during the next 5 years on account of growing government funding and support. Furthermore, rising incidence of orthopedic disorders in the region is further anticipated to boost the market growth for bio-implants over the coming years. Also, upsurge in number of CVD surgeries, on account of rising prevalence of the condition in the region is expected to aid the market growth in the next five years.”, said Mr. Karan Chechi, Research Director with TechSci Research, a research based global management consulting firm.
“Europe Bio-Implants Market By Type (Cardiovascular Bioimplants, Dental Bioimplants, Orthopedic Bioimplants, Spinal Bioimplants, and Ophthalmology Bioimplants), By Material (Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, Alloys and Natural Biomaterials), By Origin (Autograft, Allograft, Synthetic, and Others), By End-User (Hospitals, Clinics, Specialty Centers and Others), By Country, Competition, Forecast & Opportunities, 2025” has evaluated the future growth potential of Europe bio-implants market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges and opportunities in Europe bio-implants market.
Mr. Ken Mathews
708 Third Avenue,
New York – 10017